2022-2026 UK Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
April 7, 2022
VPG Market Research
972
PDF
2022-2026 UK Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
Abstract
This new study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
Report Highlights
- Business and technological trends in major markets
- Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers.
Rationale
The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
UK Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.
- Five-year test volume and sales projections.
Market Segmentation Analysis
- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Product/Technology Review
- Comparison of leading infectious disease molecular diagnostic analyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments
- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns.
Content Table of Contents I. Introduction II. Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/panels C. Computers, Software and Automation D. Auxiliary Products III. Design Criteria for Decentralized Testing Products IV. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets V. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VI. Worldwide Market and Technology Review A. DNA Sequencing B. DNA and RNA Probe Technologies C. Detection Technologies D. Instrumentation Review of latest analyzers from Abbott, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and other suppliers. E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip - Liquid Transportation and Mixing - Separation - Reaction - Detection F. Pharmacogenomics G. Major Applications 1. Microbiology/Infectious Diseases a. Overview b. Major Infectious Diseases - AIDS/HIV - Adenovirus - Aeromonads - Anthrax/Bacillus Anthracis - Arboviruses - Babesiosis - Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea) - Blastocystis Hominis - Brucella - Campylobacter - Candida - Chagas Disease - Chancroid - Chlamydia - Clostridium Difficile - Coronaviruses - Coxsackieviruses - Creutzfeldt-Jakob’s Disease - Cryptosporidium Parvum - Cyclospora Cayetanensis - Cytomegalovirus - Ebola Virus - E. Coli - EchoVirus - Encephalitis - Enteroviruses - Epstein-Barr Virus - Giardia Lamblia - Gonorrhea - Granuloma Inguinale - Hantavirus - Helicobacter Pylori - Hepatitis - Herpes Simplex Virus - Human Herpes Virus-6 (HHV-6) - Influenza Viruses - Legionella - Lyme Disease - Lymphogranuloma Venereum (LGV) - Malaria - Measles (Rubeola) - Meningitis - Microsporidium - Mononucleosis - Mumps - Mycoplasma - Papillomaviruses - Parvovirus B19 - Pneumonia - Polyomaviruses - Pseudomonas Aeruginosa - Rabies - Respiratory Syncytial Virus (RSV) - Rhinoviruses - Rotavirus - Rubella - Salmonellosis - Septicemia - Shigellosis - Staphylococcus Aureus - Streptococci - Syphilis - Toxoplasmosis - Trichomonas Vaginalis - Tuberculosis - Vibrio - West Nile Virus - Yersina 2. Forensic Testing a. Overview b. Multilocus and Single Locus Probes c. DNA Profile Data Banks d. Judicial Implementation e. Major Crime Categories f. Factors Contributing to the DNA Probe Market Expansion - Technology Availability - Use of Hair as Evidence g. Wildlife Forensics 3. Paternity Testing/HLA Typing 4. Other Applications a. Disease Susceptibility Testing b. Cardiovascular Diseases c. Diabetes d. Alzheimer’s Disease e. Periodontal Disease f. Plasma Purification g. Organ Transplantation h. Water Contamination i. Other H. Competing/Complementing Technologies 1. Monoclonal Antibodies/Immunoassays 2. RNA Probes 3. Two-Dimensional Electrophoresis 4. Flow Cytometry VII. Country Market Analyses: Infectious Disease Molecular Diagnostic Analyzers and Reagent Market Shares and Forecasts for 100 Tests--Volume and Sales Forecasts VIII. Competitive Assessments The report provides strategic assessments of over 40 leading molecular diagnostics market players and start-up companies with innovative technologies and products, including: Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, and others. IX. Appendix: Major Universities and Research Centers Developing Innovative Molecular Diagnostic Technologies and Products
This new study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
Report Highlights
- Business and technological trends in major markets
- Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers.
Rationale
The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
UK Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.
- Five-year test volume and sales projections.
Market Segmentation Analysis
- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Product/Technology Review
- Comparison of leading infectious disease molecular diagnostic analyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments
- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns.
Table of Contents I. Introduction II. Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/panels C. Computers, Software and Automation D. Auxiliary Products III. Design Criteria for Decentralized Testing Products IV. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets V. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VI. Worldwide Market and Technology Review A. DNA Sequencing B. DNA and RNA Probe Technologies C. Detection Technologies D. Instrumentation Review of latest analyzers from Abbott, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and other suppliers. E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip - Liquid Transportation and Mixing - Separation - Reaction - Detection F. Pharmacogenomics G. Major Applications 1. Microbiology/Infectious Diseases a. Overview b. Major Infectious Diseases - AIDS/HIV - Adenovirus - Aeromonads - Anthrax/Bacillus Anthracis - Arboviruses - Babesiosis - Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea) - Blastocystis Hominis - Brucella - Campylobacter - Candida - Chagas Disease - Chancroid - Chlamydia - Clostridium Difficile - Coronaviruses - Coxsackieviruses - Creutzfeldt-Jakob’s Disease - Cryptosporidium Parvum - Cyclospora Cayetanensis - Cytomegalovirus - Ebola Virus - E. Coli - EchoVirus - Encephalitis - Enteroviruses - Epstein-Barr Virus - Giardia Lamblia - Gonorrhea - Granuloma Inguinale - Hantavirus - Helicobacter Pylori - Hepatitis - Herpes Simplex Virus - Human Herpes Virus-6 (HHV-6) - Influenza Viruses - Legionella - Lyme Disease - Lymphogranuloma Venereum (LGV) - Malaria - Measles (Rubeola) - Meningitis - Microsporidium - Mononucleosis - Mumps - Mycoplasma - Papillomaviruses - Parvovirus B19 - Pneumonia - Polyomaviruses - Pseudomonas Aeruginosa - Rabies - Respiratory Syncytial Virus (RSV) - Rhinoviruses - Rotavirus - Rubella - Salmonellosis - Septicemia - Shigellosis - Staphylococcus Aureus - Streptococci - Syphilis - Toxoplasmosis - Trichomonas Vaginalis - Tuberculosis - Vibrio - West Nile Virus - Yersina 2. Forensic Testing a. Overview b. Multilocus and Single Locus Probes c. DNA Profile Data Banks d. Judicial Implementation e. Major Crime Categories f. Factors Contributing to the DNA Probe Market Expansion - Technology Availability - Use of Hair as Evidence g. Wildlife Forensics 3. Paternity Testing/HLA Typing 4. Other Applications a. Disease Susceptibility Testing b. Cardiovascular Diseases c. Diabetes d. Alzheimer’s Disease e. Periodontal Disease f. Plasma Purification g. Organ Transplantation h. Water Contamination i. Other H. Competing/Complementing Technologies 1. Monoclonal Antibodies/Immunoassays 2. RNA Probes 3. Two-Dimensional Electrophoresis 4. Flow Cytometry VII. Country Market Analyses: Infectious Disease Molecular Diagnostic Analyzers and Reagent Market Shares and Forecasts for 100 Tests--Volume and Sales Forecasts VIII. Competitive Assessments The report provides strategic assessments of over 40 leading molecular diagnostics market players and start-up companies with innovative technologies and products, including: Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, and others. IX. Appendix: Major Universities and Research Centers Developing Innovative Molecular Diagnostic Technologies and Products